BRIEF published on 08/07/2025 at 07:05, 3 months 29 days ago Carl Zeiss Meditec Reports Revenue and Earnings Growth for 2024/25 Carl Zeiss Meditec 2024/25 Revenue Ophthalmology Growth Microsurgery Sales EMEA And Americas
PRESS RELEASE published on 08/07/2025 at 07:00, 3 months 29 days ago Carl Zeiss Meditec grows revenue and earnings in the first nine months of 2024/25 Carl Zeiss Meditec AG reports revenue and earnings growth in the first nine months of 2024/25 fiscal year, with EBITA rising to €175.4m and positive contributions from various regions Revenue Growth Carl Zeiss Meditec Earnings Growth Fiscal Year 2024/25 Regional Contributions
BRIEF published on 05/13/2025 at 07:05, 6 months 23 days ago Carl Zeiss Meditec Reports Revenue Growth for First Half of 2024/25 Revenue Growth Carl Zeiss Meditec Ophthalmology DORC Acquisition US Trade Tariffs
PRESS RELEASE published on 05/13/2025 at 07:00, 6 months 23 days ago Carl Zeiss Meditec achieves revenue growth and stable operating profit in the first six months of 2024/25 Carl Zeiss Meditec AG achieves revenue growth of 10.9% and stable operating profit in the first six months of 2024/25, with a significant order entry increase of 33.4% Revenue Growth Operating Profit Carl Zeiss Meditec AG Order Entry Increase Fiscal Year 2024/25
BRIEF published on 05/07/2025 at 15:25, 6 months 28 days ago Leadership Transition at Carl Zeiss Meditec AG Carl Zeiss Meditec Leadership Change Ophthalmology Maximilian Foerst Dr. Markus Weber
PRESS RELEASE published on 05/07/2025 at 15:20, 6 months 28 days ago Change of President and CEO at Carl Zeiss Meditec AG Carl Zeiss Meditec AG announces change of President and CEO: Dr. Markus Weber steps down on 31 May 2025, to be succeeded by Maximilian Foerst on 1 June 2025. Foerst is currently Head of ZEISS Greater China Carl Zeiss Meditec AG President CEO Change Maximilian Foerst
BRIEF published on 05/07/2025 at 14:41, 6 months 28 days ago Leadership Change at Carl Zeiss Meditec AG Carl Zeiss Meditec AG Leadership Change Maximilian Foerst Management Stability Greater China Market
PRESS RELEASE published on 05/07/2025 at 14:36, 6 months 28 days ago EQS-Adhoc: Change of President and CEO at Carl Zeiss Meditec AG Carl Zeiss Meditec AG announces change of President and CEO, Dr. Markus Weber, to be succeeded by Maximilian Foerst. Handover on May 31, 2025. Foerst appointed as new Executive Board member of Carl Zeiss AG Carl Zeiss Meditec AG President CEO Change Maximilian Foerst
BRIEF published on 04/15/2025 at 09:02, 7 months 19 days ago Carl Zeiss Meditec Reports Strong Q2 Earnings for 2024/25 Revenue Growth Refractive Surgery China Market Q2 2024/25 Earnings EBITA Increase
PRESS RELEASE published on 04/15/2025 at 08:57, 7 months 19 days ago EQS-Adhoc: Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25 Carl Zeiss Meditec AG achieves significant earnings increase in Q2 2024/25, with revenue of EUR 560 million and EBITA of EUR 78 million Revenue Growth Carl Zeiss Meditec AG Earnings Increase EBITA Q2 2024/25
Published on 12/05/2025 at 02:35, 5 hours 28 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 7 hours 3 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 58 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 3 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 1 hour 3 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 32 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 8 hours 12 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 37 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 48 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 14 hours 3 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 18 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 14 hours 19 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 1 hour ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 14 hours ago Declaration of voting rights at the end of November 2025
